Search Browse Earnings

Wellgistics Health, Inc.

Nasdaq:WGRX

Wholesale-Drugs, Proprietaries & Druggists' Sundries·TAMPA, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Wellgistics Health, Inc. — SlamSEC

Revenue

$18.1M

FY 2024

Adj. EBITDA

-$1.8M

-9.7% margin

FY 2024

Net Income

-$2.9M

-16.0% margin

FY 2024

EPS (Diluted)

-$0.06

FY 2024

Stock Price

$0.17

-12.3%

2026-03-06

52W Range

$0.16 – $7.04

P/E Ratio

-2.8x

Market Cap

$14.9M

Cash

$1,364

FY 2024

Total Debt

$35.3M

FY 2024

Net Debt

$35.3M

FY 2024

Enterprise Value

$50.3M

Debt / EBITDA

-20.0x

FY 2024

EV / EBITDA

-28.5x

Employees

—

CEO

Norton Brian